Doctors tell us that “lack of time” is one of the greatest challenges in caring for patients. They often have a large caseload which means that they need to find answers to their clinical questions quickly. This challenge is increased by the need for any clinical information and recommendations to be current, from a trusted source and accessible even when wifi isn’t available.

We are transforming our acute medicine topics to bring even quicker answers at the point of care. Responding to user feedback, we are making our highest impact content more concise, more actionable with clear recommendations. Written with leading specialists, our topics emphasise the most urgent and important clinical recommendations, based on current evidence.

These topics were chosen as they were clearly identified as an area where timely clinical decision-making by frontline doctors has the greatest potential to improve patient outcomes and reduce hospital costs.

To enable the content to be practical and directive, these topics will align with the most appropriate and relevant UK and European guidelines.

These topics will be available to all of our users in the UK/Rest of World territories*

Expert panel members- transformed acute topics

John Abercrombie
General and Colorectal Surgeon at Queen’s Medical Centre, Nottingham; member of the Council of the Royal College of Surgeons of England; Clinical Lead for General Surgery, Getting It Right First Time
Disclosures: JA is a trustee and Council member of the Royal college of Surgeons of England
__________________________________________________________________________________________________

Alexander Alexiou 
Flight Doctor, Sydney HEMS
Disclosures: AA declares that he has no competing interests.
__________________________________________________________________________________________________

Jonathan Bennett
Honorary Professor of Respiratory Sciences, University of Leicester; Respiratory Consultant, Glenfield Hospital, Leicester; Chair of the British Thoracic Society
Disclosures: JB declares that he has no competing interests.
__________________________________________________________________________________________________

Johann Grundlingh
Emergency Medicine Consultant at Royal London Hospital, Barts Health NHS Trust and Honorary senior lecturer, Queen Mary University, London
Disclosures: JG declares that he has no competing interests.
__________________________________________________________________________________________________

Matthew Jones
Consultant Neurologist and Honorary Senior Lecturer at Salford Royal NHS Foundation Trust, Salford
Disclosures: MJ declares that he has no competing interests.
__________________________________________________________________________________________________

Andrew Lewington
Consultant Renal Physician and Honorary Associate Professor at Leeds Teaching Hospitals NHS Trust, Leeds 
Disclosures: AL is Associate Clinical Director of NIHR Leeds In-Vitro Diagnostics Co-operative, Co-Chair of UK Kidney Research Consortium Renal Clinical Study Group, Member of Kidney Research UK Research Grant Committee, Committee Member of NICE Kidney Injury Clinical Guideline Update 2018-20, Committee Member of NICE Diagnostic Assessment for Point of Care Creatinine Testing 2018-19. AL attended the Acute Dialysis Quality Initiative Meeting in San Diego 2018 (accommodation expenses); AL was a speaker at the AKI & CRRT Conference in San Diego 2019 (travel and accommodation expenses), the AKI Conference in Coventry 2019 (travel expenses), and the NIHR AKI and Sepsis Meeting in Leeds 2019 (no expenses).
___________________________________________________________________________________________________

Gerry Rayman
Consultant Physician and Head of Service, Diabetes and Endocrine Centre and the Diabetes Research Unit, Ipswich Hospitals NHS Trust, Ipswich
Disclosures: GR has been paid for advisory board meetings with the following companies: Safoni Aventis, Abbott Diabetes UK, Lilly Diabetes, Bayer. GR has received lecture fees from Safoni Aventis, Abbott Diabetes UK, Lilly Diabetes, Novonordisk, Napp Pharmaceuticals Ltd.

 

 

  • Excludes China, US and non-English language variants